Canada markets close in 1 hour 23 minutes
  • S&P/TSX

    20,367.02
    +79.22 (+0.39%)
     
  • S&P 500

    4,416.31
    +29.15 (+0.66%)
     
  • DOW

    35,063.86
    +225.70 (+0.65%)
     
  • CAD/USD

    0.7975
    -0.0022 (-0.28%)
     
  • CRUDE OIL

    70.35
    -0.91 (-1.28%)
     
  • BTC-CAD

    47,710.00
    -2,376.83 (-4.75%)
     
  • CMC Crypto 200

    927.34
    -16.10 (-1.71%)
     
  • GOLD FUTURES

    1,813.50
    -8.70 (-0.48%)
     
  • RUSSELL 2000

    2,214.75
    -0.74 (-0.03%)
     
  • 10-Yr Bond

    1.1770
    +0.0030 (+0.26%)
     
  • NASDAQ

    14,730.08
    +49.01 (+0.33%)
     
  • VOLATILITY

    18.00
    -1.46 (-7.50%)
     
  • FTSE

    7,105.72
    +24.00 (+0.34%)
     
  • NIKKEI 225

    27,641.83
    -139.19 (-0.50%)
     
  • CAD/EUR

    0.6721
    -0.0010 (-0.15%)
     

Chinook: Q1 Earnings Snapshot

·1 min read

SEATTLE (AP) _ Chinook Therapeutics, Inc. (KDNY) on Wednesday reported a loss of $37.2 million in its first quarter.

The Seattle-based company said it had a loss of 88 cents per share. Losses, adjusted for non-recurring costs and amortization costs, came to 83 cents per share.

The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 61 cents per share.

The drug developer posted revenue of $351,000 in the period.

Chinook shares have climbed nearly 1% since the beginning of the year. The stock has risen 45% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KDNY at https://www.zacks.com/ap/KDNY

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting